Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Antibodies Interpreted after Scrub Typhus Infection

By LabMedica International staff writers
Posted on 25 Jun 2018
Scrub typhus is a zoonotic infection caused by the bacterium Orientia tsutsugamushi. More...
It is transmitted to humans by the bite of the larval stage of trombiculid mites. With an annual incidence of about one million cases, it is an important challenge to public health in Southeast Asia.

The clinical presentation may vary from a mild febrile illness to a life-threatening disseminated infection with serious complications such as acute respiratory distress syndrome, hepatitis, renal failure, meningitis, and multiple organ failure, making the diagnosis difficult. The serological detection of IgM antibodies is the most widely used test to diagnose scrub typhus infection.

Scientists at the Christian Medical College (Vellore, India) included in this cross-sectional study, 203 patients over 18 years of age with previously confirmed scrub typhus. Scrub typhus was confirmed by positive immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) (optical density (OD) >0.8) and/or a positive polymerase chain reaction (PCR) for O. tsutsugamushi at a tertiary care teaching hospital in South India between December 2011 and March 2015.

The team performed ELISAs for IgM and IgG antibodies using the Scrub Typhus Detect kit (InBios International, Inc, Seattle, WA, USA). All patients had a positive IgM ELISA at diagnosis, of which 80 were confirmed by PCR. All patients had a blood sampling done during the study. Among them, eight patients had two blood samples taken at different time points. The time interval between confirmation of the original infection and study sample collection ranged from one month to 46 months. The overall trend showed a gradual fall in mean IgM levels over time, remaining above the threshold of positivity (OD >0.8) until 12 months after infection. The mean IgG levels showed a gradual rise, reaching a peak at 10 months post-infection, followed by a gradual decline, remaining above the cut-off threshold for more than 36 months.

The authors concluded that clinicians needed to be cautious in using a single serum sample for the detection of IgM to diagnose scrub typhus, as it remains elevated for up to 12 months after the infection, whereas the serum IgG level could be used as an indicator of past infection. The study was published in the June 2018 issue of the International Journal of Infectious Diseases.

Related Links:
Christian Medical College
InBios International

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.